According to the Joi + Blokes website, tirzepatide "works on two natural hormones in the body, GIP and GLP-1, which help control blood sugar and appetite." The FDA-approved finished drug versions of tirzepatide are approved for type 2 diabetes management (Mounjaro) and chronic weight management (Zepbound) in specific patient populations
The synergy claim is mechanistic, derived from the three peptides acting on different nodes of overlapping pathways (VEGF, NF-kB, ECM remodeling)
Some research suggests these beneficial hormonal changes may not be sustained in all patients over time, potentially contributing to weight regain in some cases
Oba peptidy navic vykazuji koncentracne zavisle, castecne bifazicke odpovedi, coz je klicove pro planovani experimentu a podrobneji se tomu venuje kapitola o davkovani
Because tirzepatide activates GIP receptors in addition to GLP-1 receptors, you get an entirely separate signaling pathway
Retatrutide is not designed for general weight loss